Kolon Investment, Inc. is a venture capital and private equity firm established in 2000 and based in Seoul, South Korea. The firm specializes in a range of investment strategies, including buyouts, mezzanine financing, corporate restructuring, growth capital, and turnaround investments. Kolon Investment primarily focuses on investing in sectors such as electronic components, petroleum, energy, computer, telecommunications equipment, healthcare, and technology. Its investment activities are concentrated in South Korea, particularly in regions like Seoul, Gyeonggi, Incheon, and Gyeongbuk.
Best Innovation is a manufacturer specializing in cosmetic products. Its mission is to provide safe alternatives to potentially harmful skincare chemicals. The company produces products composed mainly of comfortable, organic ingredients, free from controversial substances, offering customers a healthier beauty option.
Boosterz
Venture Round in 2025
Boosterz is a company that specializes in growth marketing services aimed at enhancing direct-to-consumer (D2C) brands. It supports the five key elements of marketing throughout various stages, including product planning, launch, and growth. By providing marketing assistance after making equity investments in D2C brands, Boosterz creates opportunities for these companies to operate effectively as subsidiaries. This approach allows Boosterz to foster the development and success of partner brands by leveraging strategic marketing initiatives tailored to their specific needs.
Micro-one
Venture Round in 2025
Micro-One is an air functionality expert company that manufactures incinerators, ecological infrastructure, and advanced dust filters.
IEG
Venture Round in 2024
IEG develops and supplies hardware and software in the field of mechatronics, STEM, and electrical/electronics.
Dnotitia
Seed Round in 2024
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large Language Models (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
AIDIN ROBOTICS
Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.
AGL
Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses through its software-as-a-service (SaaS) platform. This platform facilitates real-time tee-time bookings, thereby increasing convenience for golfers and driving digital innovation within the golf industry. AGL offers integrated solutions that include a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP) tailored for both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL provides cloud-based information technology solutions that enhance the management of golf facilities. Its user-friendly interface minimizes the need for face-to-face interactions and supports wireless payment options, ultimately helping golf clubs to boost their revenues while improving the overall golfing experience for players.
AGL
Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses through its software-as-a-service (SaaS) platform. This platform facilitates real-time tee-time bookings, thereby increasing convenience for golfers and driving digital innovation within the golf industry. AGL offers integrated solutions that include a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP) tailored for both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL provides cloud-based information technology solutions that enhance the management of golf facilities. Its user-friendly interface minimizes the need for face-to-face interactions and supports wireless payment options, ultimately helping golf clubs to boost their revenues while improving the overall golfing experience for players.
Creative MUT
Series A in 2024
Creative MUT is a media solutions company that specializes in content planning, production, BX, and VFX creations.
Mainline
Venture Round in 2024
Mainline is a technology company that specializes in cloud-based document management systems utilizing artificial intelligence to streamline workflows. Their platform, which has been adopted by over 300 Korean government agencies, facilitates the efficient handling of complex documents, such as regulations and contracts. Recently, Mainline developed software for insurance companies that significantly accelerates product development, reducing the time required from several months to just one week by allowing modifications to a single document. The company's offerings also include services related to technological consultancy, system integration, and application maintenance. Mainline is actively seeking foreign investors following a Series A funding round led by KB Securities.
Hej home
Series B in 2024
Hej home is the largest smart home IoT brand in Korea under GoQual Co. Ltd. Hej Home is a company that aims to create a comfortable and transformed daily life that people may not have experienced before. It turns uncomfortable moments into enjoyable ones, making everyone's dream house a part of their everyday lives.
Go-Qual
Series B in 2024
Go-Qual (고퀄) is a Korean startup that provides home network systems and security alarm systems.
withwave
Venture Round in 2023
Withwave is a leading provider of high-speed connectivity solutions, specializing in the design and manufacture of B2B connectors and cables. The company excels in delivering exceptional speed and wide bandwidth, up to 56 Gbps or more, catering to four primary markets: Wireless Communications, Test & Instrumentation, Automated Test Equipment, and Network Systems. Withwave's portfolio spans RF, Microwave, and High-Speed Solutions, with expertise in Electromagnetic Field Analysis and Signal Processing. Their products serve diverse industries such as cellular phones and base stations, data networking, semiconductor and telecommunications equipment, and factory automation. Withwave prioritizes innovation and sustainability, continually expanding its technological capabilities to maintain a competitive edge and secure long-term success.
Neurophet
Series C in 2023
Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.
EGNIS
Series B in 2023
EGNIS is a supplier of food products.
AB180
Series B in 2023
AB180 is a performance marketing firm that leverages data analytics and marketing technology to support organizations in navigating the digital landscape. The company has developed a marketing platform that enables businesses to gain insights into customer behavior by collecting and processing real-time data from mobile users. This approach helps businesses better understand their customers and enhances their marketing effectiveness, ultimately leading to improved results.
iCore
Series A in 2023
iCore specializes in developing machine vision solutions aimed at enhancing automatic inspection and analysis across various industries, including semiconductors, electronics, and automobiles. The company manufactures components and vision modules, providing advanced lenses, lighting, and semiconductor technologies. By integrating these innovative solutions, iCore enables businesses to improve their quality control processes and boost productivity through effective imaging-based technologies.
Daejin Advanced Materials
Series D in 2022
Daejin Advanced Materials Co. is a research institute that manufactures fullerene, electric, and thermally conductive polymer materials.
AIDIN ROBOTICS
Series A in 2022
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.
My Franchise
Series B in 2022
My Franchise is a company founded in 2019 in Seoul, South Korea, that addresses the information gap between franchise headquarters and potential founders. It operates an online platform that facilitates connections between these two parties, optimizing their partnership potential. The platform offers valuable insights for prospective founders, including data on the number of franchisees by year, average sales figures, and start-up costs associated with domestic franchise brands. This allows users to effectively compare and analyze important brand information across various industries, enabling informed decision-making for franchise investments.
OurBox
Series B in 2022
OurBox is a logistics agency that specializes in providing comprehensive logistics solutions and fulfillment services tailored for online sellers. The company focuses on facilitating seamless delivery of products and offers end-to-end logistics-related services for e-commerce businesses. By serving small businesses and individual sellers, OurBox enables clients to achieve their goals in product development and sales growth while benefiting from cost savings. This allows customers to concentrate on their core activities without the complexities of logistics management.
Eleven Corporation
Series A in 2022
Eleven Corporation creates value for lifestyle and beauty products.
Ledger
Series A in 2022
Ledger is a mobile ledger app that provides sales, settlement, profit, and loss management services.
Innospace
Series B in 2022
Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.
Glorang
Series A in 2022
Glorang is a prominent education technology company based in South Korea, known for its real-time online class platform, GGuge, which serves K-12 students. The platform aims to address the limitations of traditional public and private education systems by offering live instruction from experienced teachers across various subjects. Glorang has established itself as a market leader, commanding 80% of the assessment and psychology test market in Korea. The company has recently experienced significant growth, fueled by a successful Series A2 funding round, totaling approximately $20 million. In addition to its strong domestic presence, Glorang is expanding into the Asia-Pacific market with the introduction of a global AI diagnostic solution, positioning itself as a leading player in the AI-driven education sector.
Kimcaddie
Series A in 2022
Kimcaddie operates an online platform that offers comprehensive information about golf stores, enabling users to locate nearby stores and register for services. Founded in 2019 and based in Seoul, South Korea, the platform provides details on store locations, customer reviews, and available facilities. In addition to its focus on golf retail, Kimcaddie also positions itself within the screen golf sector, emphasizing an end-to-end golfing experience for users.
Uneedcomms
Series A in 2022
Uneedcomms, Inc. is a South Korean company specializing in data-driven e-commerce and marketing solutions. Founded in 2014, the company offers innovative products such as SMARTSKIN, a mobile shopping solution, and TARGETBOOK, a big data-based advertising management tool. TARGETBOOK analyzes shopping mall user behavior to optimize ad targeting and synchronizes product information in real time, facilitating effective advertising for mall retailers. Additionally, it automates the creation and editing of promotional content, allowing businesses to focus on strategic decision-making rather than repetitive tasks. Uneedcomms aims to enhance the efficiency of small and medium-sized e-commerce businesses, positioning itself as a key player in the evolving digital marketplace.
Y-Biologics
Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.
Cellebrain
Series A in 2022
Cellebrain is a biotechnology company focused on developing stem cell-based gene therapies to treat neurological disorders. The company advances its therapeutic offerings through a pipeline of candidates that utilize mesenchymal stem cells as mediators for delivering therapeutic genes. This innovative approach aims to provide new treatment options for patients suffering from chronic stroke, addressing a significant unmet medical need in the field of neurology.
ePapyrus
Series A in 2022
ePapyrus is a company that specializes in software development services, focusing on document processing solutions. It offers a platform designed to provide a standardized electronic document format, leveraging advanced artificial intelligence technologies and expertise in PDF and document technology. ePapyrus delivers robust solutions that combine heuristics with stochastic methods to achieve precise semantic understanding of complex documents. This enables developers and businesses globally to maximize the potential of their digital documents, enhancing efficiency and usability.
Ably
Series C in 2022
Ably Corporation operates a fashion platform that enables customers to buy and sell products among themselves. The platform features a forum where influencers and celebrities can establish online stores to showcase and sell their products. This model allows users to stay informed about the latest fashion trends and purchase clothing items similar to those worn by their favorite public figures. Ably aims to create a community-driven marketplace that connects consumers with the fashion choices of influential personalities.
Cyrus Therapeutics
Series B in 2022
Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.
Dataknows
Series A in 2022
Dataknows is an application that provides stock annuity, enterprise, investment, software, ICT, and data solutions.
Happy Moonday
Series A in 2021
Happy Moonday Inc. is a South Korean company founded in 2017 that specializes in manufacturing and selling organic sanitary products with a focus on women's health. The company offers a diverse range of items including organic cotton sanitary napkins, tampons, menstrual cups, underwear, feminine wash, and heating patches. Additionally, it provides menstrual cycle tracking applications to help women manage their health effectively. Happy Moonday aims to alleviate discomfort associated with menstruation, promoting a healthier lifestyle for women.
Cell Lab Med
Series B in 2021
Cell Lab Med is a drug research and development company.
Neurophet
Series B in 2021
Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.
Balaan
Series B in 2021
Balaan is an online marketplace that specializes in providing access to luxury fashion products, including clothing, accessories, and jewelry from renowned brands. By partnering with local boutiques in Europe, Balaan ensures that customers can receive the latest luxury items within three days at competitive prices, making high-end fashion more accessible. The platform aims to cater to both men and women, offering a diverse selection of multi-branded goods that appeal to fashion enthusiasts looking for quality and affordability.
Turing
Series A in 2021
Turing is a representative AI learning platform for math education.
Sellerhub
Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.
BeyondBio
Venture Round in 2021
BeyondBio is a biotechnology company focused on the research and development of synthetic pharmaceutical drugs. The firm aims to create therapeutic drugs that address life-threatening diseases for which effective treatments are currently unavailable, including pancreatic cancer, Alzheimer's disease, and glioblastoma. By developing innovative drug candidates and therapies, BeyondBio seeks to enhance the ability of medical practitioners to protect individuals from these serious health conditions.
Neuromeka
Series D in 2021
Neuromeka is a robotics technology company that specializes in developing collaborative robots designed for safe interaction with humans in manufacturing environments. The company aims to create a robot-as-a-Service (RaaS) platform, which facilitates the integration and operation of robotic automation for small and medium-sized manufacturing enterprises. By focusing on ease of use and safety, Neuromeka enables businesses to adopt robotic solutions without requiring specialized expertise, thus promoting accessibility in the automation sector. This innovative approach allows for versatile applications across various industries, enhancing productivity while ensuring a secure working environment.
CMES Robotics
Series B in 2021
CMES Robotics is an AI-powered robotics company that enables 3D vision for factory robots. CMES AI vision software includes high-precision vision sensors, robot calibration, a processing core, a simulator, and robot control. It enables robots to pick up objects that are unstructured, flexible, or deformed, as well as load and unload them. CMES Vision software has been used in void-filling and random depalletization applications all over the world.
Go-Qual
Series A in 2021
Go-Qual (고퀄) is a Korean startup that provides home network systems and security alarm systems.
iPS Bio
Series A in 2021
iPS Bio is a biotechnology company focused on developing therapies for intractable and degenerative diseases through the use of induced pluripotent stem cells (iPS cells). The company has created a drug screening platform aimed at advancing stem cell therapies specifically for nervous system disorders and other incurable conditions. By leveraging iPS technology, iPS Bio seeks to facilitate the discovery and development of new drugs that can improve patient outcomes and enhance quality of life for those affected by these challenging diseases.
Apitbio
Series A in 2021
APITBIO is a biotechnology company focused on the research and development of antibody therapeutics, particularly in the field of anti-cancer drugs. The company utilizes a specialized platform to create various types of antibodies, including monoclonal and double antibodies. Their process encompasses all stages from initial screening and discovery to optimization and production. By developing these innovative therapies, APITBIO aims to address the unmet medical needs of cancer patients and improve treatment options available in hospitals.
AffyXell Therapeutics
Series A in 2021
AffyXell Therapeutics, established in January 2020 as a joint venture between Avacta and Daewoong, focuses on the development of innovative mesenchymal stem cell (MSC) therapies. The company aims to create next-generation cell and gene therapies specifically designed to treat inflammatory and autoimmune diseases, as well as to prevent organ transplant rejection. By harnessing the therapeutic potential of MSCs, AffyXell seeks to provide health professionals with effective treatment options for a range of challenging medical conditions.
Autophagy Sciences
Series A in 2021
Autophagy Science is dedicated to developing innovative treatments for intractable diseases by leveraging a mechanism known as autophagy. The company's focus spans various therapeutic areas, including non-alcoholic steatohepatitis, inflammatory bowel disease, macular degeneration, and degenerative brain disease. By creating novel drugs that target these conditions, Autophagy Science aims to provide effective solutions for patients suffering from complex health issues, including fatty liver and liver cancer. The company's work in drug discovery emphasizes the potential of autophagy control substances to transform treatment approaches and improve patient outcomes.
Blue Farm Korea
Series A in 2020
Blue Farm Korea supplies medical consumables, medical devices, and quasi-drugs for domestic and foreign pharmaceutical companies.
Poled
Series A in 2020
Poled specializes in the development and manufacturing of advanced car seats that prioritize the safety of infant passengers. The company’s products are designed to enhance security during car travel by utilizing an intelligent safety device that preemptively engages the car seat belt in response to potential hazards, such as sudden braking or sharp turns. This innovative approach aims to mitigate the risks associated with car accidents, ensuring a safer journey for families. Poled's car seats have successfully undergone rigorous real vehicle crash tests, demonstrating their commitment to safety and reliability in automotive child passenger protection.
Agreable
Series B in 2020
Agreable is a brand commerce startup that manufactures and distributes lifestyle products.
Innospace
Series A in 2020
Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.
Kanaph Therapeutics
Series B in 2020
Kanaph Therapeutics Inc. is a biotechnology company focused on drug development, from discovery to early-stage clinical trials, primarily targeting oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company specializes in creating next-generation therapeutics, including bi-specific antibodies, Fc-fusions, and small molecules. Its oncology pipeline aims to improve immuno-stimulatory activity within the tumor microenvironment to enhance patient response rates for immuno-oncology treatments. Additionally, Kanaph Therapeutics develops therapeutic solutions for autoimmune conditions, utilizing bispecific Fc-fusions that inhibit pathways associated with complement activation and angiogenesis. The company operates in both Korea and the United States, striving to provide innovative treatments for complex diseases.
Cyrus Therapeutics
Series A in 2020
Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.
Kabrew
Series B in 2020
Kabrew is a creative craft beer company that specializes in producing handcrafted alcoholic beverages. The company focuses on using high-quality ingredients to create a diverse range of beers, allowing customers to appreciate the unique flavors and characteristics of craft brewing. Through its commitment to quality and creativity, Kabrew aims to enhance the craft beer experience for its consumers.
Select Star
Series A in 2020
Select Star is a data platform for AI technology that offers dataset building, storage, and analysis services.
Radiance
Series A in 2020
Radiance is a company that thinks of the healthy warmth of family.
Ably
Series B in 2020
Ably Corporation operates a fashion platform that enables customers to buy and sell products among themselves. The platform features a forum where influencers and celebrities can establish online stores to showcase and sell their products. This model allows users to stay informed about the latest fashion trends and purchase clothing items similar to those worn by their favorite public figures. Ably aims to create a community-driven marketplace that connects consumers with the fashion choices of influential personalities.
Datumo
Series A in 2020
Datumo, formerly known as SelectStar Inc., specializes in a cloud-based artificial intelligence data production platform. The company has developed an application called Cash Mission, which collects and analyzes data while rewarding users for their contributions. By connecting corporate clients with a network of crowd-workers, Datumo aims to address the challenges of obtaining accurate data for AI applications. The platform not only facilitates this connection but also emphasizes the importance of quality and cost-efficiency in data production. Founded in 2018 and headquartered in South Korea, Datumo continues to innovate in the field of mobile crowd-sourcing to enhance data collection processes for enterprises.
CMES Robotics
Series A in 2020
CMES Robotics is an AI-powered robotics company that enables 3D vision for factory robots. CMES AI vision software includes high-precision vision sensors, robot calibration, a processing core, a simulator, and robot control. It enables robots to pick up objects that are unstructured, flexible, or deformed, as well as load and unload them. CMES Vision software has been used in void-filling and random depalletization applications all over the world.
THE PIRATES
Series B in 2020
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.
April Bio
Series B in 2020
April Bio is a drug development company that develops antibodies and long-acting biologics.
TeamFresh
Series B in 2020
TeamFresh is a cargo and freight company that provides logistics services.
Spendit
Series A in 2020
Spendit is a B2B fintech company in Seoul, Korea.
AB180
Series A in 2020
AB180 is a performance marketing firm that leverages data analytics and marketing technology to support organizations in navigating the digital landscape. The company has developed a marketing platform that enables businesses to gain insights into customer behavior by collecting and processing real-time data from mobile users. This approach helps businesses better understand their customers and enhances their marketing effectiveness, ultimately leading to improved results.
KaiPharm
Series A in 2020
KaiPharm Co., Ltd. is a biotechnology company specializing in drug discovery and development through its innovative platform that integrates big data and artificial intelligence. The firm has developed a unique drug virtual screening algorithm, supported by an extensive in-house database that encompasses compound structures, drug-target interactions, and drug-disease relationships. One of its main projects, KMAP, focuses on generating a large drug-induced transcriptome using next-generation sequencing, which enhances drug repositioning efforts by improving prediction accuracy beyond existing public data limitations. KaiPharm's proprietary algorithms, BEAR and BACoN, leverage large-scale drug screening data without relying on structural information, enhancing the precision of predictions through advanced machine learning techniques. With years of internal research and a wealth of analytical expertise, the company aims to provide comprehensive solutions for the pharmaceutical industry, enabling it to identify novel drug indications and improve therapeutic outcomes.
Amondz
Series A in 2020
Amondz is a jewelry e-commerce platform designed to enhance the domestic jewelry market by connecting buyers and sellers. The platform offers quick access to a comprehensive production list and provides price quotations for consumers. Additionally, it emphasizes personalized customer support and consultation for sellers, facilitating a seamless interaction between both parties. By creating a reliable network of trustworthy sellers, Amondz aims to increase revenue opportunities for its clients while streamlining the purchasing process for consumers.
Balaan
Series B in 2019
Balaan is an online marketplace that specializes in providing access to luxury fashion products, including clothing, accessories, and jewelry from renowned brands. By partnering with local boutiques in Europe, Balaan ensures that customers can receive the latest luxury items within three days at competitive prices, making high-end fashion more accessible. The platform aims to cater to both men and women, offering a diverse selection of multi-branded goods that appeal to fashion enthusiasts looking for quality and affordability.
Gint
Series A in 2019
Gint is a company focused on developing advanced technologies for tractors and construction equipment manufacturers, leveraging expertise from the automotive and ICT sectors. The company addresses the global demand for electronic control and unattended automation by creating three core systems: Transmission/Hydraulic Control Units, Telematics, and Driverless Systems. These innovations are designed to assist emerging manufacturers in bridging the technological gap with established industry leaders. Gint's technologies enhance the efficiency of traditional transportation and production equipment, offering added value and improved productivity for businesses in agriculture and construction. The company collaborates with prominent domestic firms such as Tongyang Moolsan, Daedong Industrial, and SK Telecom, further solidifying its position in the market.
Neurophet
Series A in 2019
Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.
Innospace
Seed Round in 2019
Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.
Kickgoing
Seed Round in 2019
Kickgoing is a developer of a kickboard-sharing platform designed for short-distance travel. The platform enables users to easily locate available kickboards in their vicinity through a mobile app. It allows customers to book rides on demand and unlock or lock the kickboards by scanning a QR code. Additionally, Kickgoing ensures the systematic management of its fleet by performing daily checks on the condition of the kickboards, thereby providing users with reliable and convenient access to this mode of transport.
CoHive
Series B in 2019
CoHive is Indonesia's largest coworking space provider, previously known as EV Hive. The company offers a blend of coworking, coliving, coretail, and event space solutions aimed at fostering a cohesive working and living environment. With a mission to build a robust community, CoHive connects and supports startups and small to medium enterprises (SMEs) across Indonesia. The company operates approximately 33 locations in major cities including Jakarta, Medan, Yogyakarta, and Bali, catering to around 9,000 members, predominantly startups and SMEs. CoHive also provides facilities for retail spaces, allowing businesses to showcase their products within a vibrant startup community. The company's headquarters is located in Jakarta, and its leadership team includes co-founders Jason Lee and Ethan Choi, along with COO Erich Hirawan and CRO Iris Wee.
Ably
Series A in 2019
Ably Corporation operates a fashion platform that enables customers to buy and sell products among themselves. The platform features a forum where influencers and celebrities can establish online stores to showcase and sell their products. This model allows users to stay informed about the latest fashion trends and purchase clothing items similar to those worn by their favorite public figures. Ably aims to create a community-driven marketplace that connects consumers with the fashion choices of influential personalities.
AB180
Venture Round in 2019
AB180 is a performance marketing firm that leverages data analytics and marketing technology to support organizations in navigating the digital landscape. The company has developed a marketing platform that enables businesses to gain insights into customer behavior by collecting and processing real-time data from mobile users. This approach helps businesses better understand their customers and enhances their marketing effectiveness, ultimately leading to improved results.
Future Medicine
Series B in 2019
Future Medicine Co., Ltd. is a South Korean drug development company founded in 2015 and located in Seongnam. It focuses on creating innovative treatments, specializing in anti-cancer, anti-inflammation, fibrosis, and anti-viral medications. The company utilizes its Nucleoside Library Platform to facilitate drug discovery across various therapeutic areas, including oral medications, diabetic nephropathy, autoimmune diseases, and viral infections such as the Zika virus. Future Medicine is committed to advancing healthcare through the development of multi-target anti-cancer therapies and cancer immunotherapy, aiming to address significant medical needs and improve patient outcomes.
M.MONSTAR
Series C in 2019
M.MONSTAR is a software development firm that specializes in e-commerce solutions for fashion shopping malls.
Millie
Series C in 2019
Millie is an online book reading application.
PR&D Company
Series B in 2019
PR&D Company designs and develops hey dealer app and website for car-selling services.
M.MONSTAR
Series B in 2018
M.MONSTAR is a software development firm that specializes in e-commerce solutions for fashion shopping malls.
Millie
Series B in 2018
Millie is an online book reading application.
Kickgoing
Seed Round in 2018
Kickgoing is a developer of a kickboard-sharing platform designed for short-distance travel. The platform enables users to easily locate available kickboards in their vicinity through a mobile app. It allows customers to book rides on demand and unlock or lock the kickboards by scanning a QR code. Additionally, Kickgoing ensures the systematic management of its fleet by performing daily checks on the condition of the kickboards, thereby providing users with reliable and convenient access to this mode of transport.
ProtoPie
Series A in 2018
ProtoPie is a software company that specializes in an interactive prototyping tool enabling designers and engineers to create sophisticated prototypes without the need for coding. Its platform allows users to transform UI and UX design concepts into highly interactive prototypes for mobile, desktop, web, and IoT applications. This intuitive tool facilitates the ideation, iteration, and innovation processes, helping users effectively plan, communicate, and demonstrate their product ideas. ProtoPie's capabilities have garnered recognition and adoption from leading global brands, demonstrating its relevance and effectiveness in overcoming contemporary design challenges.
Future Medicine
Series A in 2018
Future Medicine Co., Ltd. is a South Korean drug development company founded in 2015 and located in Seongnam. It focuses on creating innovative treatments, specializing in anti-cancer, anti-inflammation, fibrosis, and anti-viral medications. The company utilizes its Nucleoside Library Platform to facilitate drug discovery across various therapeutic areas, including oral medications, diabetic nephropathy, autoimmune diseases, and viral infections such as the Zika virus. Future Medicine is committed to advancing healthcare through the development of multi-target anti-cancer therapies and cancer immunotherapy, aiming to address significant medical needs and improve patient outcomes.
Korea Credit Data
Series A in 2018
Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.
J2H Biotech
Series B in 2018
J2H Biotech is a bio-venture company dedicated to the development of small-molecule drugs aimed at treating rare and challenging diseases. The company focuses on enhancing the oral absorption rates of its synthetic drugs and employs innovative patent-linked systems to facilitate the availability of generic medications for conditions such as intractable rare diseases, infectious diseases, and liver diseases. By advancing these therapeutic alternatives, J2H Biotech seeks to improve patient outcomes and expand treatment options for healthcare providers.
Wantedlab
Series B in 2017
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer job applicants to companies and earn rewards when those applicants are hired. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, all of which utilize Wanted to identify and recruit top talent in Asia. Since its inception, Wantedlab has raised over $20 million in funding and is actively expanding its presence to major cities worldwide.
Dunamu
Series C in 2017
Dunamu Inc. is a South Korean company founded in 2012 that specializes in blockchain and securities services. It operates UPbit, a prominent global cryptocurrency exchange, as well as Stockplus, a securities information and trading platform, and U-Stockplus, an over-the-counter platform for private company trading. Additionally, Dunamu offers Luniverse, a blockchain-as-a-service solution, and Onboard, an equity management platform designed for private companies to manage shareholder equity electronically. The company's services are accessible through a mobile application, which provides users with real-time cryptocurrency prices and analytics, ensuring a secure and user-friendly trading experience across various markets.
Andar
Venture Round in 2017
Andar Co., Ltd., established in 2015 and headquartered in Paju, South Korea, operates a multi-channel retail business focused on fashion and lifestyle products. The company specializes in designing, manufacturing, and selling athletic and gym wear for women and children, catering to both online and offline markets through its e-commerce platform and physical stores.
Eutilex
Series A in 2016
Eutilex Co., Ltd. is a biotechnology company based in South Korea that specializes in the development of immunotherapy technologies aimed at treating tumors. The company focuses on anti-tumor T cell therapy and antibody therapeutics, creating innovative treatments to combat cancer. Eutilex's product pipeline includes advanced therapies such as T Cell Therapy (4-1BB CTL), CAR-T, and various antibody-based treatments. The company markets its offerings throughout South Korea, contributing to the growing field of cancer immunotherapy.
Albam
Series A in 2016
Albam : A mobile based HR Solution that is available for both Managers(Admins) and Staffs in App both IOS & Android. The average HR manager spends 45 minutes a day to calculate time attendance & payroll. With Albam, time is reduced by 70% to only 15 minutes. Albam help enterprises in simplifying and automating their time attendance system to payroll solution. Our easy to use and simple Cloud based Human Resource solution helps companies in reducing the high costs that are often associated in the investment of Time Attendance system which includes the purchase of expensive fingerprint machines and training of IT Personnels. With Albam, employees can clock in and clock out directly right away from their smartphone, clock in and clock out has never been this easier with Albam.
Newploy
Series A in 2016
Newploy is a South Korean company, established in 2014, that specializes in developing a payroll work automation platform. The software utilizes robotic process automation (RPA) technology to streamline payroll tasks, including salary calculation, transfer, reporting, and payment. Additionally, it offers workforce management solutions that help businesses track employee work hours and manage various payroll-related functions. Newploy's platform centralizes crucial aspects of staffing needs, such as leave management, attendance tracking, and work scheduling, thereby enhancing operational efficiency for organizations.
White Life Science
Series B in 2016
White Life Science is a pharmaceutical company focused on the development and production of various medicines aimed at improving human health. The company specializes in creating both prescription and over-the-counter drugs, including those for digestive health. In addition to drug development, White Life Science provides medication information to help patients understand their treatment options for a range of diseases. Through its comprehensive approach, the company aims to enhance patient care and access to effective pharmaceuticals.
Treasure Hunter
Venture Round in 2015
Treasure Hunter Co., Ltd. is a media content and marketing solutions provider based in Seoul, South Korea. Founded in 2015, the company specializes in creating and distributing engaging mobile video content, catering primarily to the Asian market. Treasure Hunter offers a range of services, including incubating systems for media creators that encompass loyalty programs, channel optimization, live production support, and marketing strategies. Additionally, the company provides brand analysis and strategies for effective content creation and YouTube channel management. It also runs an educational institute focused on image planning, photography, copyright, and legal knowledge relevant to the media industry. Through its comprehensive offerings, Treasure Hunter supports content producers and brands in enhancing their online marketing and advertising efforts.
AptaBio Therapeutics
Series A in 2015
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, that specializes in the discovery and development of selective inhibitors targeting the NOX family of enzymes, as well as aptamer-based anti-cancer drugs. The company's product offerings include a range of transfection reagents designed for DNA or RNA delivery into eukaryotic cells. AptaBio is advancing several product candidates aimed at addressing significant health issues, including PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 for non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics focuses on creating innovative solutions for complex medical challenges.
C-TRI
Venture Round in 2014
C-TRI is involved in the manufacturing and advancement of pharmaceutical products. C-Tri Co., Ltd., based in Namyangju, South Korea, specializes in the production and development of pharmaceutical products. They offer a wide range of products, including peptides, antiviral drugs, ionic liquids, and more. Additionally, C-Tri Co., Ltd. provides OTC and ETC contract services. The company was established in 1998.
SeeOn
Venture Round in 2012
SeeOn (씨온) is a Korean location-based social network service that allows users to contact other users and share experiences with one another. Established in 2012, SeeOn was awarded the social networking app of the year in 2012 in the LBS smart app awards.
SUNDAYTOZ
Venture Round in 2010
SundayToz is a South Korean company specializing in the development of casual games. Founded in 2009 and headquartered in Seongnam, Gyeonggi-do, it creates games for various platforms, including Kakao Talk, Apple's App Store, Google Play, Facebook, and Naver, catering to both smartphone and personal computer users. The company's first application was launched in December 2009 on Cyworld. Notably, in December 2012, SundayToz was honored with the Republic of Korea Presidential Award for its contributions to next-generation-targeted content.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.